Selected research
Industry Research
Animal Pharmaceutical Industry Research Report 2026
Market perspective
The global Animal Pharmaceutical market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Animal Pharmaceutical is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Animal Pharmaceutical is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Animal Pharmaceutical include Merck, Zoetis, Virbac, Vétoquinol, Ringpu Biology, PARNELL, MSD Animal Health Australia, Merial and Jurox, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Animal Pharmaceutical market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal Pharmaceutical Market by Company
Merck
Zoetis
Virbac
Vétoquinol
Ringpu Biology
PARNELL
MSD Animal Health Australia
Merial
Jurox
Elanco
Ceva Sante Animale
CAHIC
Boehringer Ingelheim Vetmedica
Bayer Animal Health
Animal Pharmaceutical Segment by Type
Vaccine
Veterinary Drugs
Other
Animal Pharmaceutical Segment by Application
Companion Animal
Poultry
Other
Animal Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Animal Pharmaceutical manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Animal Pharmaceutical by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Animal Pharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vaccine
- Veterinary Drugs
- Other
Applications
- Companion Animal
- Poultry
- Other
Companies covered
- Merck
- Zoetis
- Virbac
- Vétoquinol
- Ringpu Biology
- PARNELL
- MSD Animal Health Australia
- Merial
- Jurox
- Elanco
- Ceva Sante Animale
- CAHIC
- Boehringer Ingelheim Vetmedica
- Bayer Animal Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Animal Pharmaceutical Market Size (2021-2032)
- 2.2.2 Global Animal Pharmaceutical Sales (2021-2032)
- 2.2.3 Global Animal Pharmaceutical Market Average Price (2021-2032)
- 2.3 Animal Pharmaceutical by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vaccine
- 2.3.3 Veterinary Drugs
- 2.3.4 Other
- 2.4 Animal Pharmaceutical by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Companion Animal
- 2.4.3 Poultry
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Animal Pharmaceutical Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Animal Pharmaceutical Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Animal Pharmaceutical Revenue of Manufacturers (2021-2026)
- 3.4 Global Animal Pharmaceutical Average Price by Manufacturers (2021-2026)
- 3.5 Global Animal Pharmaceutical Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Animal Pharmaceutical, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Animal Pharmaceutical, Product Type & Application
- 3.8 Global Manufacturers of Animal Pharmaceutical, Established Date
- 3.9 Global Animal Pharmaceutical Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Company Information
- 4.1.2 Merck Business Overview
- 4.1.3 Merck Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Animal Pharmaceutical Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 Zoetis
- 4.2.1 Zoetis Company Information
- 4.2.2 Zoetis Business Overview
- 4.2.3 Zoetis Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zoetis Animal Pharmaceutical Product Portfolio
- 4.2.5 Zoetis Recent Developments
- 4.3 Virbac
- 4.3.1 Virbac Company Information
- 4.3.2 Virbac Business Overview
- 4.3.3 Virbac Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Virbac Animal Pharmaceutical Product Portfolio
- 4.3.5 Virbac Recent Developments
- 4.4 Vétoquinol
- 4.4.1 Vétoquinol Company Information
- 4.4.2 Vétoquinol Business Overview
- 4.4.3 Vétoquinol Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Vétoquinol Animal Pharmaceutical Product Portfolio
- 4.4.5 Vétoquinol Recent Developments
- 4.5 Ringpu Biology
- 4.5.1 Ringpu Biology Company Information
- 4.5.2 Ringpu Biology Business Overview
- 4.5.3 Ringpu Biology Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ringpu Biology Animal Pharmaceutical Product Portfolio
- 4.5.5 Ringpu Biology Recent Developments
- 4.6 PARNELL
- 4.6.1 PARNELL Company Information
- 4.6.2 PARNELL Business Overview
- 4.6.3 PARNELL Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 PARNELL Animal Pharmaceutical Product Portfolio
- 4.6.5 PARNELL Recent Developments
- 4.7 MSD Animal Health Australia
- 4.7.1 MSD Animal Health Australia Company Information
- 4.7.2 MSD Animal Health Australia Business Overview
- 4.7.3 MSD Animal Health Australia Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MSD Animal Health Australia Animal Pharmaceutical Product Portfolio
- 4.7.5 MSD Animal Health Australia Recent Developments
- 4.8 Merial
- 4.8.1 Merial Company Information
- 4.8.2 Merial Business Overview
- 4.8.3 Merial Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Merial Animal Pharmaceutical Product Portfolio
- 4.8.5 Merial Recent Developments
- 4.9 Jurox
- 4.9.1 Jurox Company Information
- 4.9.2 Jurox Business Overview
- 4.9.3 Jurox Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jurox Animal Pharmaceutical Product Portfolio
- 4.9.5 Jurox Recent Developments
- 4.10 Elanco
- 4.10.1 Elanco Company Information
- 4.10.2 Elanco Business Overview
- 4.10.3 Elanco Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Elanco Animal Pharmaceutical Product Portfolio
- 4.10.5 Elanco Recent Developments
- 4.11 Ceva Sante Animale
- 4.11.1 Ceva Sante Animale Company Information
- 4.11.2 Ceva Sante Animale Business Overview
- 4.11.3 Ceva Sante Animale Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Ceva Sante Animale Animal Pharmaceutical Product Portfolio
- 4.11.5 Ceva Sante Animale Recent Developments
- 4.12 CAHIC
- 4.12.1 CAHIC Company Information
- 4.12.2 CAHIC Business Overview
- 4.12.3 CAHIC Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 CAHIC Animal Pharmaceutical Product Portfolio
- 4.12.5 CAHIC Recent Developments
- 4.13 Boehringer Ingelheim Vetmedica
- 4.13.1 Boehringer Ingelheim Vetmedica Company Information
- 4.13.2 Boehringer Ingelheim Vetmedica Business Overview
- 4.13.3 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product Portfolio
- 4.13.5 Boehringer Ingelheim Vetmedica Recent Developments
- 4.14 Bayer Animal Health
- 4.14.1 Bayer Animal Health Company Information
- 4.14.2 Bayer Animal Health Business Overview
- 4.14.3 Bayer Animal Health Animal Pharmaceutical Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bayer Animal Health Animal Pharmaceutical Product Portfolio
- 4.14.5 Bayer Animal Health Recent Developments
5 Global Animal Pharmaceutical Market Scenario by Region
- 5.1 Global Animal Pharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Animal Pharmaceutical Sales by Region: 2021-2032
- 5.2.1 Global Animal Pharmaceutical Sales by Region: 2021-2026
- 5.2.2 Global Animal Pharmaceutical Sales by Region: 2027-2032
- 5.3 Global Animal Pharmaceutical Revenue by Region: 2021-2032
- 5.3.1 Global Animal Pharmaceutical Revenue by Region: 2021-2026
- 5.3.2 Global Animal Pharmaceutical Revenue by Region: 2027-2032
- 5.4 North America Animal Pharmaceutical Market Facts & Figures by Country
- 5.4.1 North America Animal Pharmaceutical Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Animal Pharmaceutical Sales by Country (2021-2032)
- 5.4.3 North America Animal Pharmaceutical Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Animal Pharmaceutical Market Facts & Figures by Country
- 5.5.1 Europe Animal Pharmaceutical Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Animal Pharmaceutical Sales by Country (2021-2032)
- 5.5.3 Europe Animal Pharmaceutical Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Animal Pharmaceutical Market Facts & Figures by Country
- 5.6.1 Asia Pacific Animal Pharmaceutical Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Animal Pharmaceutical Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Animal Pharmaceutical Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Animal Pharmaceutical Market Facts & Figures by Country
- 5.7.1 South America Animal Pharmaceutical Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Animal Pharmaceutical Sales by Country (2021-2032)
- 5.7.3 South America Animal Pharmaceutical Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Animal Pharmaceutical Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Animal Pharmaceutical Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Animal Pharmaceutical Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Animal Pharmaceutical Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Animal Pharmaceutical Sales by Type (2021-2032)
- 6.1.1 Global Animal Pharmaceutical Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Animal Pharmaceutical Sales Market Share by Type (2021-2032)
- 6.2 Global Animal Pharmaceutical Revenue by Type (2021-2032)
- 6.2.1 Global Animal Pharmaceutical Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Animal Pharmaceutical Revenue Market Share by Type (2021-2032)
- 6.3 Global Animal Pharmaceutical Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Animal Pharmaceutical Sales by Application (2021-2032)
- 7.1.1 Global Animal Pharmaceutical Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Animal Pharmaceutical Sales Market Share by Application (2021-2032)
- 7.2 Global Animal Pharmaceutical Revenue by Application (2021-2032)
- 7.2.1 Global Animal Pharmaceutical Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Animal Pharmaceutical Revenue Market Share by Application (2021-2032)
- 7.3 Global Animal Pharmaceutical Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Animal Pharmaceutical Value Chain Analysis
- 8.1.1 Animal Pharmaceutical Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Animal Pharmaceutical Production Mode & Process
- 8.2 Animal Pharmaceutical Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Animal Pharmaceutical Distributors
- 8.2.3 Animal Pharmaceutical Customers
9 Global Animal Pharmaceutical Analyzing Market Dynamics
- 9.1 Animal Pharmaceutical Industry Trends
- 9.2 Animal Pharmaceutical Industry Drivers
- 9.3 Animal Pharmaceutical Industry Opportunities and Challenges
- 9.4 Animal Pharmaceutical Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst